Search Results - Chengdang Xu

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Identification of key genes participating in copper-diethyldithiocarbamate-related cell death process and predicting the development of prostate cancer by Xin’an Wang, Chengdang Xu, Junjie Ma, Xiao Wang, Xi Chen

    Published in Discover Oncology (2024-10-01)
    Get full text
    Article


  2. 2

    Exploration of the influence of GOLGA8B on prostate cancer progression and the resistance of castration-resistant prostate cancer to cabazitaxel by Haopeng Li, Xin’an Wang, Menghe Zhai, Chengdang Xu, Xi Chen

    Published in Discover Oncology (2024-05-01)
    Get full text
    Article


  3. 3

    Study on clinical outcomes between non-transecting urethroplasty and lingual mucosal urethroplasty for iatrogenic bulbar urethral stricture treatment by Wei Le, Denglong Wu, Chengdang Xu, Weidong Zhou, Chao Li

    Published in Basic and Clinical Andrology (2023-05-01)
    Get full text
    Article


  4. 4

    Identification of BBC3 as a novel indicator for predicting prostate cancer development and olaparib resistance by Junjie Ma, Xin Qin, Wei Le, Xi Chen, Xiao Wang, Chengdang Xu

    Published in Discover Oncology (2024-09-01)
    Get full text
    Article


  5. 5

    Efficacy and safety of bipolar androgen therapy in castration-resistant prostate cancer following abiraterone or enzalutamide resistance: A systematic review by Xiangyun You, Shan Huang, Xin’an Wang, Cheng Yi, Niandong Gong, Junfeng Yu, Chengdang Xu, Zhendong Xiang

    Published in Frontiers in Endocrinology (2023-04-01)
    Get full text
    Article


  6. 6

    CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer by Xi Chen, Yechen Wu, Xinan Wang, Chengdang Xu, Licheng Wang, Jingang Jian, Denglong Wu, Gang Wu

    Published in European Journal of Medical Research (2022-07-01)
    Get full text
    Article


  7. 7

    Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression by Zhe Hong, Chengdang Xu, Shengfeng Zheng, Xinan Wang, Yiran Tao, Yao Tan, Guowen Lin, Denglong Wu, Dingwei Ye

    Published in Cell Death Discovery (2023-10-01)
    Get full text
    Article


  8. 8

    Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide by Zhe Hong, Zhendong Xiang, Pan Zhang, Qiang Wu, Chengdang Xu, Xinan Wang, Guowei Shi, Zongyuan Hong, Denglong Wu

    Published in Clinical and Translational Medicine (2021-07-01)
    Get full text
    Article


  9. 9

    PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling by Tao Yang, Yongnan Chi, Xin’an Wang, Chengdang Xu, Xi Chen, Ying Liu, Shengsong Huang, Xuyou Zhu, Haoyang Zhang, Hui Zhuo, Denglong Wu

    Published in Cell Death and Disease (2024-02-01)
    Get full text
    Article


  10. 10

    Risk factor analysis and nomogram development for predicting 28-day mortality in elderly ICU patients with sepsis and type 2 diabetes mellitus by Haopeng Li, Yaru Zu, Qinghua Wang, Tong Zi, Xin Qin, Yan Zhao, Wei Jiang, Xin’an Wang, Chengdang Xu, Xi Chen, Gang Wu

    Published in European Journal of Inflammation (2024-08-01)
    Get full text
    Article


  11. 11

    Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma by Yifan Liu, Yuntao Yao, Yu Zhang, Chengdang Xu, Tianyue Yang, Mingyu Qu, Bingnan Lu, Xu Song, Xiuwu Pan, Wang Zhou, Xingang Cui

    Published in BMC Medical Genomics (2024-05-01)
    Get full text
    Article


Search Tools: